saplin

Compare funds

Quant Multi Cap vs Mahindra Manulife Multi Cap

Both are multi cap funds. Over the last 3 years Quant Multi Cap returned 10.8% a year and Mahindra Manulife Multi Cap 18.1%, against a category median of 15.1%. Quant Multi Cap costs 1.08% a year and Mahindra Manulife Multi Cap 0.95%. On the saplin Score Quant Multi Cap rates 2.8 (Weak) and Mahindra Manulife Multi Cap 7.7 (Neutral) within their category. 11.5% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

Quant Multi CapMahindra Manulife Multi CapCategory median
saplin Score (0–10)2.8 Weak7.7 Neutral—
1-year return8.4%11.8%6.2%
3-year return, a year10.8%18.1%15.1%
5-year return, a year10.9%14.9%13.4%
Volatility (standard deviation)18.3%17.2%16.8%
Sharpe ratio0.330.680.56
Beta1.010.980.94
Upside capture99111104
Downside capture1109695
Expense ratio (Direct)1.08%0.95%0.95%
Fund size₹7,721 cr₹7,383 cr₹3,488 cr
Number of holdings577278
Top 10 holdings, share of fund49.6%30.4%27.0%
Portfolio P/E29.325.228.7
Lead manager—Vishal Jajoo (1 yr)—
Launched19 Feb 200111 May 2017—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

Quant Multi Cap and Mahindra Manulife Multi Cap have 11.5% of their portfolios in the same stocks (7 holdings in common, portfolios as of 30 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsQuant Multi CapMahindra Manulife Multi Cap
Divi's Laboratories2.59%5.36%
Adani Enterprises4.29%2.52%
Adani Energy Solutions1.87%1.63%
Sun TV Network2.75%1.61%
Torrent Pharmaceuticals1.41%2.29%
Glenmark Pharmaceuticals3.41%0.96%
Nippon Life India Asset Management2.21%0.79%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.